The European Federation of Pharmaceutical Industries and Associations (EFPIA) is preparing to publish an update on variable rates of access to new medicines in 15 May 2023
Research from IQVIA shows that the use of medicines in the USA is slowing, with growth down to 5% in 2022, reaching a total value of $429 billion on a net price 3 May 2023
As senior figures from the UK biopharma industry gathered in a gloomy London for the Annual Conference of The Association of the British Pharmaceutical Industry 28 April 2023
German generics drugmaker STADA Arzneimittel and Sweden’s Xbrane Biopharma are working together on a supply agreement for Ximluci (ranibizumab). 27 April 2023
The British Generic Manufacturers Association (BGMA) is seeking a judicial review of the decision on the part of the UK government to exclude it from negotiatio 24 April 2023
A draft evidence report from Boston, USA-based watchdog The Institute for Clinical and Economic Review (ICER) suggests a cost-effective price of up to $1.9 mill 13 April 2023
A newly-published cost effectiveness analysis for Tarpeyo (budesonide) could help developer Calliditas Therapeutics increase sales in the USA, where the therapy 12 April 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.